Loading…
Corbus Pharmaceuticals Holdings, Inc. is projected to rise to $13.36 by 2027, a +38% move from its current price of $9.68. CRBP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $9.36 | $9.69 | $10.03 | +0.12% |
| Jul 15 | $9.24 | $9.70 | $10.18 | +0.23% |
| Jul 16 | $9.15 | $9.71 | $10.31 | +0.35% |
| Jul 17 | $9.08 | $9.72 | $10.41 | +0.46% |
| Jul 18 | $9.02 | $9.74 | $10.51 | +0.58% |
| Jul 19 | $8.96 | $9.75 | $10.60 | +0.69% |
| Jul 20 | $8.91 | $9.76 | $10.68 | +0.81% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.91 | $9.76 | $10.68 | +0.81% |
| Week 2 | $8.65 | $9.84 | $11.18 | +1.62% |
| Week 3 | $8.48 | $9.92 | $11.60 | +2.45% |
| Week 4 | $8.34 | $10.00 | $11.98 | +3.28% |
| Week 5 | $8.23 | $10.08 | $12.34 | +4.11% |
| Week 6 | $8.14 | $10.16 | $12.68 | +4.95% |
| Week 7 | $8.06 | $10.24 | $13.02 | +5.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Corbus Pharmaceuticals Holdings, Inc. is a healthcare company described as a clinical stage company that develops and commercializes therapeutics for cancer and obesity.
Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity.
The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is currently trading at $9.07.
The stock has a market cap of $168.05M and is ranked 3964, reflecting a small-cap position within the healthcare space.
The forecast implies a bullish price trajectory, with the Avg forecast rising from $9.07 in 2026 to $16.39 in 2030, then to $52.81 in 2040 and to $89.92 in 2050, while the max forecast climbs to $14.29 in 2026, $25.94 in 2030, $101.33 in 2040, and $193.00 in 2050.
Near term, the 30-day range is $7.01-$11.74, with SMA50 at $9.29 and SMA200 at $10.19, outlining near-term price movements within a defined corridor.
A major floor 31.7% below — a decisive break under it would weaken the trend.
The nearest floor, 23.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 25.5% above — clearing it would confirm fresh momentum.
Key CRBP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRBP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.45 | Buy | $9.50 | Buy |
| MA 10 | $9.27 | Buy | $9.25 | Buy |
| MA 20 | $8.72 | Buy | $8.97 | Buy |
| MA 50 | $9.20 | Buy | $9.01 | Buy |
| MA 100 | $9.19 | Buy | $9.21 | Buy |
| MA 200 | $10.14 | Sell | $9.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.85 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 116.42 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.18 | Buy |
| ROC (12) | 14.42 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.05 | Buy |
| Awesome (5,34) | 0.93 | Buy |
| Ultimate (7,14,28) | 64.57 | Neutral |
| Momentum (10) | 1.43 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 9.71 | Sell |
| ADX (14) | 15.46 | Neutral |
| ATR (14) | 0.26 | Info |
The 30-day technical picture is bullish.
RSI14 is 60, with the 50-day simple moving average at $9.29 and the 200-day simple moving average at $10.19, indicating price momentum that is near-term positive but nuanced by nearby moving averages.
The 30-day range spans $7.01 to $11.74, with a defined support at $7.38 and resistance at $11.51, suggesting potential upside if near-term resistance is surpassed.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.38 | $9.68 | $14.65 | 0% | Neutral | |
| $10.39 | $13.36 | $18.33 | +38% | Bullish | |
| $10.88 | $14.51 | $20.82 | +50% | Bullish | |
| $11.47 | $15.77 | $23.42 | +63% | Bullish | |
| $12.20 | $17.22 | $26.33 | +78% | Bullish | |
| $12.00 | $17.36 | $27.22 | +79% | Bullish | |
| $15.30 | $22.64 | $36.32 | +134% | Bullish | |
| $19.10 | $28.89 | $47.29 | +198% | Bullish | |
| $18.81 | $29.05 | $48.46 | +200% | Bullish | |
| $19.94 | $31.41 | $53.31 | +224% | Bullish | |
| $28.78 | $49.67 | $90.61 | +413% | Bullish | |
| $42.56 | $86.47 | $174.98 | +793% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.38 | $9.68 | $11.66 | +0.00% |
| August 2026 | $8.67 | $10.30 | $12.62 | +6.41% |
| September 2026 | $8.97 | $10.75 | $13.35 | +4.37% |
| October 2026 | $8.85 | $10.69 | $13.43 | -0.60% |
| November 2026 | $8.96 | $10.89 | $13.82 | +1.93% |
| December 2026 | $9.36 | $11.44 | $14.65 | +5.06% |
Click any year to see its month-by-month CRBP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Corbus Pharmaceuticals Holdings, Inc.'s 2026 outlook centres on $9.68, within a $7.38 to $14.65 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CRBP could reach as high as $18.33, with a base case around $13.36 and support toward $10.39 — roughly +38% from $9.68. Buyers look set to stay in control over this stretch.
Expect CRBP to range from $10.88 to $20.82 through 2028. The $14.51 average target implies a +50% move from current prices. That is up +9% on the projected 2027 average. Momentum favours further upside here.
The CRBP price prediction for 2029 points to an average of $15.77 (low $11.47, high $23.42) — a potential gain of +63% on today's $9.68. Buyers look set to stay in control over this stretch.
In 2030, CRBP is projected to trade between $12.20 and $26.33, averaging $17.22 — a potential gain of +78% from today's $9.68. That is up +9% on the projected 2029 average. Momentum favours further upside here.
Corbus Pharmaceuticals Holdings, Inc.'s 2031 outlook centres on $17.36, within a $12.00 to $27.22 range. That is up +1% on the projected 2030 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CRBP could reach as high as $36.32, with a base case around $22.64 and support toward $15.30 — roughly +134% from $9.68. Momentum favours further upside here.
Expect CRBP to range from $19.10 to $47.29 through 2033. The $28.89 average target implies a +198% move from current prices. That is up +28% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The CRBP price prediction for 2034 points to an average of $29.05 (low $18.81, high $48.46) — a potential gain of +200% on today's $9.68. Momentum favours further upside here.
In 2035, CRBP is projected to trade between $19.94 and $53.31, averaging $31.41 — a potential gain of +224% from today's $9.68. That is up +8% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Corbus Pharmaceuticals Holdings, Inc.'s 2040 outlook centres on $49.67, within a $28.78 to $90.61 range. That is up +58% on the projected 2035 average. That marks a +413% change versus current levels. Momentum favours further upside here.
By 2050, CRBP could reach as high as $174.98, with a base case around $86.47 and support toward $42.56 — roughly +793% from $9.68. Buyers look set to stay in control over this stretch.
Investing $1,000 in CRBP today (≈ 103.305785 CRBP) could be worth
$8,932.77
+$7,932.77 (+793%) by 2050 · US Dollar
Based on the average projected CRBP price of $86.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRBPwould be worth at today's price.
$1,000 invested in CRBP on Jul 10, 2025 (≈ 119.61723 CRBP) would be worth
$1,157.89
+$157.89 (+15.8%) today · 1.16× · US Dollar
Based on a CRBP entry price of $8.36 vs. today's $9.68.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.25 | $1,046.49 | +4.6% |
| 1 month ago | $7.7 | $1,257.14 | +25.7% |
| 3 months ago | $9.8 | $987.76 | -1.2% |
| 6 months ago | $7.99 | $1,211.51 | +21.2% |
| 1 year ago | $8.36 | $1,157.89 | +15.8% |
| All time (5.0y) ago | $47.1 | $205.52 | -79.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRBP forecast.
Our base-case forecast reaches $19.00 around 2032.
Implied market cap at $19.00: $352.03M
The multi-year forecast shows a bullish trajectory with rising averages across years.
By 2030, the Avg price is $16.39 with ROI 80.7 and sentiment BULLISH, continuing a steady upward path from 2026 through 2031.
By 2040, the Avg price is $52.81 with ROI 482.2 and sentiment BULLISH, reflecting substantial upside potential over the longer horizon.
By 2050, the Avg price is $89.92 with ROI 891.4 and sentiment BULLISH, indicating the highest long-term upside in this forecast scenario.
Tap a question to reveal the answer.
Avg $16.39; min $11.23; max $25.94; ROI 80.7; sentiment BULLISH.
The forecast shows bullish sentiment in multiple years with rising Avg prices and positive ROI projections (e.g., 39.2% in 2027, 57.1% in 2028, up to 891.4% by 2050). These are estimates, not guarantees.
Yes—the max forecast reaches $101.33 by 2040 and $193.00 by 2050.
Current price $9.07; market cap $168.05M.
Sentiment BULLISH; RSI14 60; SMA50 $9.29; SMA200 $10.19; 30-day range $7.01-$11.74; support $7.38; resistance $11.51.
Corbus Pharmaceuticals Holdings, Inc. Community Discussion
0Share your Corbus Pharmaceuticals Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.